Delving into a Clinical Update on Azeliragon for GBM- Implementable Lessons for Small Molecule Success

Time: 11:30 am
day: Conference Day 1


  • In animal models of glioblastoma, azeliragon combined with radiation enhanced survival while overcoming the immunosuppressive tumor microenvironment
  • Two phase II clinical trials of azeliragon, in combination with radiation with or without temozolomide, in newly diagnosed glioblastoma are in progress
  • The effect of azeliragon on cerebral edema and ability to reduce dexamethasone dosing will be evaluated in the azeliragon studies in GBM